Haemophilus Influenzae Type B Vaccine Market Size And Share

  • Report Code : TIPRE00008513
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Haemophilus Influenzae B형 백신 시장 점유율 분석 및 기회 [2025-2031]

Buy Now

Haemophilus Influenzae Type B Vaccine Market Report Haemophilus Influenzae Type B Vaccine Market Scope and Analysis Haemophilus Influenzae Type B Vaccine Market Size and Share

Haemophilus Influenzae Type B Vaccine Market Report Analysis

Haemophilus Influenzae Type B Vaccine Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • GlaxoSmithKline plc
  • Lanzhou Institute of Biological Products Co., Ltd.
  • McKesson Corporation
  • Medline Industries, Inc.
  • Merck Sharp & Dohme Corp.
  • Novartis AG
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Walvax Biotechnology Co., Ltd.

Regional Overview

  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미
  • 중동 및 아프리카

Market Segmentation

By 유형
  • HIB 백신
  • DTaP-IPV
By 제형
  • 액체 1가 HIB
  • 액체 복합 HIB
  • 동결건조 1가 HIB
  • 동결건조 복합 HIB
By 응용분야
  • 병원
  • 연구 및 학술 실험실
  • 제약 및 생명공학 회사
  • 기타
By 지리
  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미